Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Sewell

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Pediatrics|November 4, 2000
Chest compressions in an infant with osteogenesis imperfecta type II: No new rib fracturesR D Sewell, M A Steinberg
European Journal of Pharmacology|September 22, 1989
Evaluation of selective actions of dopamine D-1 and D-2 receptor agonists and antagonists on opioid antinociceptionK F Rooney, R D Sewell
Neuropharmacology|August 1, 1985
Hyperphagia induced by 2-deoxy-D-glucose in the presence of the delta-opioid antagonist ICI 174,864H C Jackson, R D Sewell
Psychopharmacology|January 1, 1984
The involvement of mu- and kappa- but not delta-opioid receptors in the body weight gain of suckling ratsH C Jackson, R D Sewell
The Journal of Pharmacy and Pharmacology|August 1, 1982
Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: comparison with opioid receptor agonistsM M Ben-Sreti, R D Sewell
Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1984
Comparison of the relative effects of aspirin, mefenamic acid, dihydrocodeine, dextropropoxyphene and paracetamol on visceral pain, respiratory rate and prostaglandin biosynthesisR D Sewell, J P Gonzalez, J Pugh
Journal of Enzyme Inhibition|January 1, 1991
Novel inhibitors of enkephalin-degrading enzymes. III: 4-Carboxymethylamino-4-oxo-3 (phenylamino) butanoic acids as enkephalinase inhibitorsA Patel, H J Smith, R D Sewell
Neuropharmacology|October 1, 1983
Characterization of a kappa-agonist-like antinociceptive action of tifluadomN Upton, J P Gonzalez, R D Sewell
European Journal of Pharmacology|March 10, 2000
Potentiation of opioid-induced conditioned place preference by the selective serotonin reuptake inhibitor fluoxetineF Subhan, D M Pache, R D Sewell
Progress in Medicinal Chemistry|January 1, 1993
Inhibitors of enkephalin-degrading enzymes as potential therapeutic agentsA Patel, H J Smith, R D Sewell
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Pediatrics|November 4, 2000
Chest compressions in an infant with osteogenesis imperfecta type II: No new rib fracturesR D Sewell, M A Steinberg
European Journal of Pharmacology|September 22, 1989
Evaluation of selective actions of dopamine D-1 and D-2 receptor agonists and antagonists on opioid antinociceptionK F Rooney, R D Sewell
Neuropharmacology|August 1, 1985
Hyperphagia induced by 2-deoxy-D-glucose in the presence of the delta-opioid antagonist ICI 174,864H C Jackson, R D Sewell
Psychopharmacology|January 1, 1984
The involvement of mu- and kappa- but not delta-opioid receptors in the body weight gain of suckling ratsH C Jackson, R D Sewell
The Journal of Pharmacy and Pharmacology|August 1, 1982
Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: comparison with opioid receptor agonistsM M Ben-Sreti, R D Sewell
Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1984
Comparison of the relative effects of aspirin, mefenamic acid, dihydrocodeine, dextropropoxyphene and paracetamol on visceral pain, respiratory rate and prostaglandin biosynthesisR D Sewell, J P Gonzalez, J Pugh
Journal of Enzyme Inhibition|January 1, 1991
Novel inhibitors of enkephalin-degrading enzymes. III: 4-Carboxymethylamino-4-oxo-3 (phenylamino) butanoic acids as enkephalinase inhibitorsA Patel, H J Smith, R D Sewell
Neuropharmacology|October 1, 1983
Characterization of a kappa-agonist-like antinociceptive action of tifluadomN Upton, J P Gonzalez, R D Sewell
European Journal of Pharmacology|March 10, 2000
Potentiation of opioid-induced conditioned place preference by the selective serotonin reuptake inhibitor fluoxetineF Subhan, D M Pache, R D Sewell
Progress in Medicinal Chemistry|January 1, 1993
Inhibitors of enkephalin-degrading enzymes as potential therapeutic agentsA Patel, H J Smith, R D Sewell
Pageof 5